How Novartis' Double-Stacked Failures Reverberated Through Biopharma
Key Points:
- Investor’s Business Daily (IBD) provides information for educational purposes only and does not offer investment advice or recommendations to buy or sell securities.
- The data presented is sourced from what IBD believes are reliable providers, but accuracy, timeliness, and suitability are not guaranteed.
- Past investment performance shared by IBD does not predict or ensure future results, and authors may hold positions in discussed stocks.
- Real-time market prices are provided by Nasdaq Last Sale, but not all market data is included; ownership and estimate data come from LSEG and FactSet respectively.
- IBD and its associated marks are trademarks of Investor’s Business Daily, LLC, which holds all rights reserved as of 2026.